Coils
Ultipaq Cerecyte
A non-bioabsorbable, implantable device intended to induce a neurovascular thrombosis to treat an intracranial aneurysm and/or neurovascular arteriovenous malformation (AVM); it may also be intended to treat non-neurovascular malformations. It is in the form of a metal [e.g., platinum alloy] or metal/synthetic polymer wire which coils upon deployment within the aneurysm/vasculature; it is typically pre-attached to a nonimplantable delivery wire. Disposable devices associated with implantation (e.g., delivery wire, catheter) may be included.
Ultipaq Cerecyte models and sizes
From the FDA Global Unique Device Identification Database. Confirm with the manufacturer's instructions for use.
| Model / catalog no. | Size | MRI | Status |
|---|---|---|---|
| CFS100201-30 | Length 1 cm; Length 190 cm | MR Conditional | Available |
| CFS100202-30 | Length 2 cm; Length 190 cm | MR Conditional | Available |
| CFS100203-30 | Length 3 cm; Length 190 cm | MR Conditional | Available |
| CFS100204-30 | Length 4 cm; Length 190 cm | MR Conditional | Available |
| CFS100206-30 | Length 6 cm; Length 190 cm | MR Conditional | Available |
| CFS100208-30 | Length 8 cm; Length 190 cm | MR Conditional | Available |
| CFS100252-30 | Length 2 cm; Length 190 cm | MR Conditional | Available |
| CFS100254-30 | Length 4 cm; Length 190 cm | MR Conditional | Available |
| CFS100256-30 | Length 6 cm; Length 190 cm | MR Conditional | Available |
| CFS100258-30 | Length 8 cm; Length 190 cm | MR Conditional | Available |
| CFS100302-30 | Length 2 cm; Length 190 cm | MR Conditional | Available |
| CFS100304-30 | Length 4 cm; Length 190 cm | MR Conditional | Available |
| CFS100306-30 | Length 6 cm; Length 190 cm | MR Conditional | Available |
| CFS100308-30 | Length 8 cm; Length 190 cm | MR Conditional | Available |
| CFS100402-30 | Length 2 cm; Length 190 cm | MR Conditional | Available |
| CFS100404-30 | Length 4 cm; Length 190 cm | MR Conditional | Available |
| CFS100406-30 | Length 6 cm; Length 190 cm | MR Conditional | Available |
| CFS100408-30 | Length 8 cm; Length 190 cm | MR Conditional | Available |
FDA clearances
- 510(k) K082739 October 2008
Procedures that use coils
Frequently asked questions
What is Ultipaq Cerecyte used for?
A non-bioabsorbable, implantable device intended to induce a neurovascular thrombosis to treat an intracranial aneurysm and/or neurovascular arteriovenous malformation (AVM); it may also be intended to treat non-neurovascular malformations. It is in the form of a metal [e.g., platinum alloy] or metal/synthetic polymer wire which coils upon deployment within the aneurysm/vasculature; it is typically pre-attached to a nonimplantable delivery wire. Disposable devices associated with implantation (e.g., delivery wire, catheter) may be included.
Who makes Ultipaq Cerecyte?
Ultipaq Cerecyte is made by Medos International Sàrl. It is listed under embolization coils in our device library.
What sizes does Ultipaq Cerecyte come in?
Sizes listed for Ultipaq Cerecyte: Length: 1–190 cm. Confirm availability with the manufacturer's instructions for use.
Is Ultipaq Cerecyte MRI safe?
The FDA device database lists Ultipaq Cerecyte as MR Conditional. Always follow the specific MRI conditions in the labeling.
Is Ultipaq Cerecyte FDA cleared?
Ultipaq Cerecyte is covered by FDA submission K082739.
How do I contact a Medos International Sàrl sales representative?
Medos International Sàrl has not listed representatives on LA Vascular yet. Visit the Medos International Sàrl company page for contact details.
Models, sizes and MRI status come from the FDA Global Unique Device Identification Database (GUDID); descriptions marked "provided by the manufacturer" are reviewed before publishing. Not an endorsement; follow the manufacturer's instructions for use.